Intelligence Platform
Patents
Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7582641
Gyrase inhibitors and uses thereof
granted patentUS 7582605
Phosphorus-containing hepatitis C serine protease inhibitors
granted patentUS 7582662
Body weight gain inhibitor
granted patentUS 7582676
2-phenylpyran-4-one derivatives as selective COX-2 inhibitors
granted patentUS 7579357
Dipeptidyl peptidase inhibitors
granted patentUS 7576065
Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concu
granted patentUS 7572914
Kinase inhibitors
granted patentUS 7569580
Heterotricyclic compounds for use as HCV inhibitors
granted patentUS 7569591
Gyrase inhibitors and uses thereof
granted patentUS 7566719
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
granted patentUS 7557106
Substituted pyrimidines useful as protein kinase inhibitors
granted patentUS 7553852
Caspase inhibitors and uses thereof
granted patentUS 7550598
Kinase inhibitors
granted patentUS 7550590
Dipeptidyl peptidase inhibitors
granted patentUS 7547698
Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (S
granted patentUS 7547794
Compositions useful as inhibitors of protein kinases
granted patentUS 7541381
Non-covalent inhibitors of AmpC Ξ²-lactamase
granted patentUS 7531570
Treatment of diseases using ICE inhibitors
granted patentUS 7531556
Compositions useful as inhibitors of rock and other protein kinases
granted patentUS 7531536
Pyrazole compounds useful as protein kinase inhibitors
granted patentUS 7528142
Aminopyrimidines useful as kinase inhibitors
granted patentUS 7528138
Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases
granted patentUS 7527934
Labeled substrate conjugates for identifying enzyme inhibitors
granted patentUS 7521475
Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use
granted